ANKRD25 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of ANKRD25, a protein belonging to the ankyrin repeat domain (ANKRD) family. Proteins in this family are characterized by ankyrin repeat motifs, which are known to mediate protein-protein interactions. ANKRD25 is involved in various cellular processes, including signal transduction, protein regulation, and intracellular organization. By participating in these processes, ANKRD25 helps modulate cellular responses and the interactions between different proteins. Inhibitors of ANKRD25 disrupt these protein-protein interactions, thereby affecting the pathways in which ANKRD25 is involved.
Structurally, ANKRD25 inhibitors can vary widely depending on their mode of action. Some may interact directly with the ankyrin repeat motifs, preventing ANKRD25 from binding to its target proteins. Others may alter the protein's conformation, hindering its ability to participate in cellular complexes or interfere with its localization within the cell. These inhibitors provide valuable insights into the role of ANKRD25 in biological systems, particularly in terms of how it regulates cellular processes such as protein folding, signal transduction, and the organization of structural complexes within cells. By inhibiting ANKRD25, researchers can dissect the specific pathways and interactions in which this protein plays a key role, offering a deeper understanding of the molecular mechanisms that govern cellular functions, protein networks, and structural integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a MEK inhibitor, PD98059 can inhibit the MAPK/ERK pathway, which may be involved in the cellular processes that ANKRD25 participates in. The inhibition can affect ANKRD25's functionality indirectly. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a p38 MAPK inhibitor. By inhibiting p38, it can indirectly affect the signaling cascades where ANKRD25 is a player, modulating its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor SP600125 can modulate the JNK signaling pathway, potentially affecting ANKRD25, which may have roles in these pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, LY294002 can impact AKT phosphorylation and thereby potentially influence the pathways involving ANKRD25. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can indirectly modulate the activity of ANKRD25 by affecting PI3K-AKT signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
This compound inhibits Rho-associated kinase and can modulate cytoskeleton dynamics, thereby potentially influencing the functions or localization of ANKRD25. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, and by doing so, can impact various signaling pathways that may involve ANKRD25. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
This is a calcium chelator. By modulating intracellular calcium levels, it can indirectly affect calcium-dependent signaling pathways where ANKRD25 may function. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 inhibits CaMKII, thereby influencing calcium signaling. This can indirectly impact the functional scope of ANKRD25 within cellular signaling frameworks. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein can indirectly affect the phosphorylation status of proteins within the signaling pathways where ANKRD25 is involved. | ||||||